From: Evaluation of a multicomponent pathway to address inpatient delirium on a neurosciences ward
Before Care Pathway (n = 197 patients) | After Care Pathway (n = 194 patients) | p-value | |
---|---|---|---|
Age, median (IQR) | 71 (62–80) | 72 (64–81) | 0.77 |
Female, no. (%) | 112 (57) | 96 (49) | 0.14 |
Race, no. (%) | 0.92 | ||
White | 111 (56) | 107 (55) | |
Black | 12 (6.1) | 11 (5.7) | |
Asian / Pacific Islander | 42 (21) | 50 (26) | |
Other / Unknown | 32 (16) | 26 (13) | |
Hispanic | 23 (12) | 13 (6.7) | 0.24 |
Modified Charlson comorbidity score, median (IQR) | 5 (3–6) | 5 (3–6) | 0.83 |
Prior cognitive impairment, no. (%) | 65 (33) | 61 (31) | 0.74 |
Primary Hospital Service, no. (%) | 0.014 | ||
Neurology | 54 (27) | 65 (34) | |
Neurosurgery | 102 (52) | 91 (47) | |
Hospital medicine | 29 (15) | 36 (19) | |
Other | 12 (6.1) | 2 (1.0) |